Publication details

Identificationof novel therapeutic options for venetoclax-resistant AML cells through drug repurposing.

Investor logo

LADUNGOVÁ Adriana BUŠA Daniel LODHI Yusuf HÝL Jan ČULEN Martin ŠMÍDA Michal

Year of publication 2023
Type Conference abstract
MU Faculty or unit

Central European Institute of Technology

Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info